Israel’s Polyrizon is developing innovative medical device hydrogels delivered in the form of nasal sprays. These can trap incoming pathogens to protect individuals, but also deliver medicines efficiently into the bloodstream to treat disease. Polyrizon has raised $4.2 million on NASDAQ.

https://www.globenewswire.com/news-release/2024/10/30/2971841/0/en/Polyrizon-Announces-Closing-of-4-2-Million-Initial-Public-Offering.html

https://polyrizon-biotech.com/

https://www.youtube.com/watch?v=7gkBTr7Gu2g